SAB Biotherapeutics, Inc.: Form DEF 14A, filed Dec 18, 2023
Filed with the SEC on Dec 18, 2023 and accepted by EDGAR at Dec 18, 2023, 14:34 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-23-070950. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.